CDC: Limited Availability of Alternative Yellow Fever Vaccine

Stamaril received approval in the U.S. through the FDA's investigational new drug (IND) program
Stamaril received approval in the U.S. through the FDA's investigational new drug (IND) program

The Centers for Disease Control and Prevention (CDC) has released a list of clinics stocking the yellow fever vaccine, Stamaril (Sanofi Pasteur). They have also created an interactive map allowing travelers and clinicians to easily search locations with the vaccine that are nearest to them. The map will be updated periodically to include any updates to clinic locations.

The distribution of Stamaril is due to the total depletion of YF-Vax, the only licensed yellow fever vaccine in the U.S. Sanofi Pasteur has stated they expect YF-Vax to be available again by the end of 2018. 

Stamaril, which is manufactured in France, received approval through the Food and Drug Administration's investigational new drug (IND) program (despite the name, the vaccine is not investigational or experimental and has been used in Europe for years). It is comparable to YF-Vax in safety and efficacy.

As part of the IND program, only a limited number of clinics will be provided Stamaril.  

Related Articles

For more information and to view the map, visit CDC.gov. Travelers can visit CDC.gov/travel to see which countries require yellow fever vaccination before entry.